Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 6c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts CLBT Hot Sheet
Join SI Premium – FREE
Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $95.7 million versus the consensus estimate of $92.19 million.
GUIDANCE:
Cellebrite DI Ltd. sees Q3 2024 revenue of $100-104 million, versus the consensus of $95 million.
Cellebrite DI Ltd. sees FY2024 revenue of $390-398 million, versus the consensus of $378 million.
For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Lockheed Martin wins $114.6M F-35 navigation system contract
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
